Loading...

Laboratory Corporation of America Holdings (NYSE:LH)

254.67 USD +2.28 USD ( +0.9% )
Watchlist Manager
Laboratory Corporation of America Holdings Logo
Laboratory Corporation of America Holdings
NYSE:LH
Watchlist

Intrinsic Value

The intrinsic value of one LH stock under the Base Case scenario is 305.7 USD. Compared to the current market price of 254.67 USD, Laboratory Corporation of America Holdings is Undervalued by 17%.

The Intrinsic Value is calculated as the average of the two valuation methods:

Undervaluation 17%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Fundamental Analysis

LH Profitability Score
Profitability Due Diligence

Laboratory Corporation of America Holdings's profitability score is 59/100. The higher the profitability score, the more profitable the company is.

Negative 1-Year Revenue Growth
Positive Net Income
Positive Revenue Growth Forecast
Positive 3-Year Average ROIC
59/100
Profitability
Score

Laboratory Corporation of America Holdings's profitability score is 59/100. The higher the profitability score, the more profitable the company is.

LH Solvency Score
Solvency Due Diligence

Laboratory Corporation of America Holdings's solvency score is 61/100. The higher the solvency score, the more solvent the company is.

Positive Net Debt
Short-Term Liabilities
Long-Term Liabilities
High Altman Z-Score
61/100
Solvency
Score

Laboratory Corporation of America Holdings's solvency score is 61/100. The higher the solvency score, the more solvent the company is.

Wall Street
Price Targets

LH Price Targets
Price Targets made by Wall Street

Wall Street analysts forecast LH stock price to rise over the next 12 months.

12-month price targets for LH stock made by Wall Street professionals. The average price target is 309.92 USD with a low forecast of 267.65 USD and a high forecast of 336 USD.

Lowest
Price Target
267.65 USD
5% Upside
Average
Price Target
309.92 USD
22% Upside
Highest
Price Target
336 USD
32% Upside
View Analyst Estimates
View Analyst Estimates

Insider Trading

LH Insider Trading
Buy and sell transactions by insiders

Laboratory Corporation of America Holdings insiders have sold more shares than they have bought in the past 3 months.

During the last 3 months Laboratory Corporation of America Holdings insiders bought 10.2k USD , and sold 8.8M USD worth of shares. The last transaction was made on Aug 3, 2022 by Glenn A Eisenberg, who sold 8.2M USD worth of LH shares.

Sold
0-3
months
8.8M USD
2
3-6
months
931k USD
3
6-9
months
251k USD
2
9-12
months
1.3M USD
1
Bought
0-3
months
1
10.2k USD
3-6
months
1
923k USD
6-9
months
0
0 USD
9-12
months
0
0 USD
Cumulative Transactions Amount
Period Sold Bought Net
3 Months
8.8M USD
10.2k USD
-8.8M
6 Months
9.7M USD
933k USD
-8.8M
9 Months
10M USD
933k USD
-9.1M
12 Months
11.3M USD
933k USD
-10.4M
Date Value Insider Name Amount Avg Price
2022-08-03
Sell
8 151 474 USD
Glenn A Eisenberg -32 100 253.94 USD
2022-08-01
Sell
665 638 USD
Peter J Wilkinson -2 576 258.4 USD
2022-06-07
Buy
10 172 USD
Brian J Caveney +42 242.19 USD
2022-03-29
Sell
652 871 USD
Mark S Schroeder -2 356 277.11 USD
2022-03-25
Sell
156 145 USD
R Sanders Williams -572 272.98 USD
2022-03-10
Sell
65 290 USD
Amy B Summy -249 262.21 USD
2022-02-16
Buy
922 810 USD
Peter M Neupert +3 500 263.66 USD
2022-02-15
Sell
56 714 USD
Mark S Schroeder -207 273.98 USD
2022-02-07
Sell
56 586 USD
Mark S Schroeder -204 277.38 USD
2022-02-03
Sell
43 761 USD
Mark S Schroeder -161 271.81 USD
2021-12-15
Sell
151 130 USD
Dwight Gary Gilliland -500 302.26 USD
2021-09-15
Sell
1 335 510 USD
Der Vaart Sandra D Van -4 500 296.78 USD
2021-06-07
Sell
1 199 520 USD
Der Vaart Sandra D Van -4 500 266.56 USD
2021-05-06
Sell
691 375 USD
Paul R Kirchgraber -2 500 276.55 USD
2021-05-03
Sell
699 816 USD
Jean-Luc Belingard -2 600 269.16 USD
2021-03-30
Sell
168 004 USD
Mark S Schroeder -667 251.88 USD
2021-02-18
Sell
559 579 USD
Peter J Wilkinson -2 317 241.51 USD
2020-11-06
Sell
126 179 USD
Mark S Schroeder -588 214.59 USD
2020-11-04
Sell
321 210 USD
Paul R Kirchgraber -1 500 214.14 USD
2020-07-08
Sell
225 056 USD
R Sanders Williams -1 300 173.12 USD
Why is insider trading important?

Competitors

Competitors Valuation
Laboratory Corporation of America Holdings Competitors

Shareholder Return

LH Price
Laboratory Corporation of America Holdings

1M 1M
+4%
6M 6M
-8%
1Y 1Y
-15%
3Y 3Y
+55%
5Y 5Y
+62%
Annual Price Range
254.67
52w Low
213.86
52w High
313.3
Price Metrics
Average Annual Return 8.95%
Standard Deviation of Annual Returns 24.02%
Max Drawdown -47%

Company Profile

Laboratory Corporation of America Holdings

Country

United States of America

Industry

Health Care

Market Cap

23.2B USD

Dividend Yield

1.14%

Description

Laboratory Corp. of America Holdings operates as a life sciences company, which engages in the provision of vital information to help health professionals make clear and confident decisions. The company is headquartered in Burlington, North Carolina and currently employs 75,500 full-time employees. The Company’s business segments include Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). Through its Dx and DD segments, the Company provides diagnostic, drug development and technology enabled solutions. The firm also supports clinical trial activity in approximately 100 countries through its industry central laboratory, preclinical, and clinical development businesses. Dx segment operates through a network of patient service centers, branches, rapid response laboratories, primary laboratories, and specialty laboratories. DD segment, which operates on a global scale. The firm serves a range of customers, including doctors, hospitals, pharmaceutical companies, researchers, governmental agencies, physicians and other healthcare providers. The company also helps in delivering non-clinical testing services.

Contact

NORTH CAROLINA
Burlington
358 S Main St
+13362291127.0
https://www.labcorp.com

IPO

1991-04-24

Employees

75 500

Officers

Pres, CEO & Chairman
Mr. Adam H. Schechter
CFO & Exec. VP
Mr. Glenn A. Eisenberg
Exec. VP, Pres of Diagnostics & Chief Medical Officer
Dr. Brian J. Caveney M.P.H., M.D., J.D., MPH
Exec. VP and Pres of Diagnostics Laboratory Operations & Global Supply Chain
Mr. Mark S. Schroeder
Exec. VP & CEO of Covance Drug Devel.
Dr. Paul R. Kirchgraber M.D.
Laboratory Director of Operations
Dr. Michelle Abelson Ph.D.
Show More
Sr. VP & Chief Accounting Officer
Mr. Peter J. Wilkinson
Exec. VP and Chief Information & Technology Officer
Mr. Lance V. Berberian
Chief Scientific Officer & Sr. VP
Dr. Marcia T. Eisenberg Ph.D.
VP of Investor Relations
Chas Cook
Show Less

See Also

Similar Stocks

LH Stock FAQ

What is the Intrinsic Value of one LH stock?

The intrinsic value of one LH stock under the Base Case scenario is 305.7 USD.

Is LH stock undervalued or overvalued?

Compared to the current market price of 254.67 USD, Laboratory Corporation of America Holdings is Undervalued by 17%.